VTT Printed a Morphine Test on Paper
News Apr 18, 2015
VTT is the first in the world to have developed a drug test printed on paper. VTT used antibodies - produced by methods of molecular biology - as morphine sensing molecules when creating this printing technology-based morphine test. Using printing technology to manufacture rapid tests enables high production volumes and low production costs.
A paper-based test enables a rapid analysis of whether a compound - in this case, morphine - is present in a given sample. Possible future applications of the developed test include drug testing at workplaces and in connection with traffic control.
This method, developed by VTT Technical Research Centre of Finland Ltd, provides several advantages, such as high production volumes, low material costs and disposability as well as design freedom based on bendability and foldability of paper.
"In 2010, we proved that the VTT method works in a hemoglobin assay. Through our continued development efforts, we wanted to confirm that the method also works in mass-production of more demanding tests. Morphine as a small-sized molecule places major requirements on the analytical performance of the test. In the future, the new method will also present an opportunity to simultaneously analyze other drugs of abuse and residues of pharmaceuticals and their metabolites from one and the same sample", says Tomi Erho, Principal Scientist at VTT.
Morphine and hemoglobin tests have shown that paper is an excellent platform for various antibody-based tests. In rapid testing, paper can replace nitrocellulose, which is typically used as a reaction and flow substrate, to provide a very low-cost, lightweight and biodegradable material alternative. In the future, paper could also become a competitive alternative for commonly used plastic-based assay platforms.
Printing technology will be a low-cost method for the manufacture of rapid tests designed for the use of consumers, businesses and authorities for instance in the areas of health, welfare and the environment.
Rapid diagnostics and the expansion of testing outside clinical and analytical laboratories to patients and other end-users is a rising trend. Printing of tests on paper will provide entirely new opportunities for innovations based on the mass production of home test kits.
The research was performed at VTT as part of research projects mainly funded by Tekes - the Finnish Funding Agency for Innovation.
H7N9 Influenza Vaccine Clinical Trials CommenceNews
Two new clinical trials testing an experimental vaccine to prevent influenza caused by an H7N9 influenza virus are now enrolling volunteers at sites across the United States. The Phase 2 studies will test different dosages of the inactivated influenza vaccine candidate as well as different vaccination schedules. The studies also will evaluate whether an adjuvant boosts the immune responses of people receiving the vaccine.
Study Extends Potential of Personalized Cell-based ImmunotherapiesNews
New methods developed for the study could be applied to devise personalized, cell-based immunotherapies for epithelial ovarian cancer or other types of tumorsREAD MORE
Alternative to Antibiotics: Antibody Approach for Treating Multidrug-Resistant Bacterial InfectionsNews
Researchers are developing a promising alternative to antibiotic treatment for infections caused by Klebsiella pneumoniae bacteria resistant to carbapenem antibiotics. The approach uses antibodies to target the K. pneumoniae protective capsule polysaccharide.READ MORE
Comments | 0 ADD COMMENT
International Conference on Molecular Biology and Stem Cells
Aug 13 - Aug 15, 2018
World Congress on Plant Science and Molecular Biology
Sep 12 - Sep 13, 2018